Sophisticated Purchasing of Pharmaceuticals —Learning From Other Countries

In 2019 and early 2020, drug pricing in the United States was a top concern of the public and therefore of politicians. President Trump, the moderate Democrats, the progressive Democrats, and some Republicans competed to denounce louder and regulate more substantially the manner by which pharmaceutical firms set their prices.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research